Catabasis Pharmaceuticals Inc Share Price Nasdaq
Equities
US14875P1075
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 504M 42.09B |
---|---|---|---|---|---|
Net income 2024 * | -79M -6.6B | Net income 2025 * | -101M -8.43B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.93
x | P/E ratio 2025 * |
-4.66
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.7% |
Latest transcript on Catabasis Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 26/08/26 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 01/11/01 |
Chief Tech/Sci/R&D Officer | - | 15/22/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 01/14/01 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 04/19/04 |
Director/Board Member | 75 | 05/16/05 |
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.21% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |